Sarepta Therapeutics

Cambridge Company Ready To Deploy New Ebola DrugAs the Ebola crisis continues to worsen in West Africa, a Cambridge Biotech company is developing ways to help in the fight.
Sarepta Reports Positive Results In Fight Against Duchenne Muscular DystrophyA medical conference in San Francisco is still buzzing in reaction to some positive clinical results from a Cambridge biotech which is trying to attack a disease that kills children.